Although most of the innovation in treatment has come in the past decade, new treatments for glaucoma are still being tested, albeit at a slower pace.

A couple drops in your eye usually brings relief, not concern—but a rare recall case highlights the importance of a clean, ...

Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

Fort Worth, Texas-based Alcon Laboratories has voluntarily recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, which are packaged in batches of 25.

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

The reason for the recall is that "eggs from a positive Salmonella environment were shipped into distribution to retail facilities," according to the FDA. Handsome Brook Farms issued the voluntary ...

Eylea (aflibercept) is a prescription drug that treats certain eye conditions. Eylea can cause side effects that range from mild to serious. An example includes cataracts, which may become a long ...

McDonald’s Australia is set to release a “one of a kind” item that includes a divisive Aussie staple in the mix. McDonald’s Australia has introduced Vegemite Shaker fries. The brand said ...

But after thousands of complaints about complications, the FDA issued an open letter to veterinarians to be alert to symptoms like paralysis, even death. On Dec. 16, 2024, the Food and Drug ...

A breakthrough treatment developed by a group of Chinese researchers to treat a rare but deadly eye cancer has been granted ... Food and Drug Administration (FDA). The medication was jointly ...

Oysters harvested from December 2 to December 17 by Ruco’s Shellfish from a portion of Hammersley Inlet growing area in Washington state were potentially contaminated, the FDA said in a Thursday ...

Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...